NCT02380872

Brief Summary

The main objective of this study was to evaluate the matrix metalloproteinase (MMP)-8, and -9, tissue inhibitor of matrix metalloproteinase and interleukin-1beta levels in gingival crevicular fluid during the early and late stages of healing for gingival recession sites treated by coronally advanced flap plus platelet rich fibrin (PRF) compared to CAF plus connective tissue graft. As PRF consists of several growth factors, it may enhance the healing potential of soft tissues, the investigators hypothesized that using PRF in the treatment of gingival recessions might regulate inflammation and promote wound healing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 14, 2015

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 5, 2015

Completed
Last Updated

March 5, 2015

Status Verified

March 1, 2015

Enrollment Period

11 months

First QC Date

February 14, 2015

Last Update Submit

March 2, 2015

Conditions

Keywords

Gingival recessionfibrinconnective tissuegingival crevicular fluidmatrix metalloproteinasecytokine

Outcome Measures

Primary Outcomes (4)

  • Change from Baseline in MMP-8 gingival crevicular fluid level at 10 days, 1, 3 and 6 months

    Baseline, 10 days, 1, 3 and 6 months

  • Change from Baseline in MMP-9 gingival crevicular fluid level at 10 days, 1, 3 and 6 months

    Baseline, 10 days, 1, 3 and 6 months

  • Change from Baseline in TIMP-1 gingival crevicular fluid level at 10 days, 1, 3 and 6 months

    Baseline, 10 days, 1, 3 and 6 months

  • Change from Baseline in IL-1beta gingival crevicular fluid level at 10 days, 1, 3 and 6 months

    Baseline, 10 days, 1, 3 and 6 months

Secondary Outcomes (1)

  • Gingival recession depth

    6 months

Study Arms (2)

Connective tissue graft

ACTIVE COMPARATOR

Connective tissue graft Soft tissue harvested from palatum of the subjects.

Procedure: Connective tissue graft

Platelet Rich Fibrin

EXPERIMENTAL

Autogenous platelet and leukocyte fibrin material was obtained from blood.

Procedure: Platelet Rich Fibrin

Interventions

gingival recession treated with connective tissue graft

Connective tissue graft

gingival recession treated with platelet rich fibrin

Platelet Rich Fibrin

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Similar bilateral Miller Class I or II localized gingival recessions at least ≥ 2 mm located on incisors, canines or premolars on both jaws
  • Identifiable cementoenamel junction
  • Age ≥ 18 years
  • Presence of tooth vitality and absence of restorations and superficial caries in the area to be treated
  • No periodontal surgical treatment in the previous 24 months on the involved sites
  • Sufficient palatal donor tissue for the indicated SCTG.

You may not qualify if:

  • Smoking
  • Patients with a pregnancy or lactation period or self-reported history of antibiotic medication within three months
  • Molar, mobile or teeth with crown or filling were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ege University School of Dentistry Department of Periodontology

Izmir, 35100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Gingival Recession

Condition Hierarchy (Ancestors)

Gingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesPeriodontal Atrophy

Study Officials

  • Gülnihal Eren, PhD. Dr.

    Ege University School of Dentistry

    PRINCIPAL INVESTIGATOR
  • Gül Atilla, Professor

    Ege University School of Dentistry

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

February 14, 2015

First Posted

March 5, 2015

Study Start

October 1, 2012

Primary Completion

September 1, 2013

Study Completion

October 1, 2013

Last Updated

March 5, 2015

Record last verified: 2015-03

Locations